LETTER
New Synthesis of Substituted Cyclopentanes
719
(5) (a) Paquette, L. A. Org. React. 1971, 25, 1. (b) Clough, J.
M. Comprehensive Organic Synthesis, Vol. 3; Trost, B., Ed.;
Pergamon: Oxford, 1991, 861.
(6) (a) Mąkosza, M.; Przyborowski, J.; Klajn, R.; Kwast, A.
Synlett 2000, 1773. (b) Mąkosza, M.; Judka, M. Chem.–Eur.
J. 2002, 8, 4234.
CDCl3): d = 2.17–2.33 (m, 2 H), 2.89 [dt, 3J(H,H) = 6.60,
14.43 Hz, 1 H], 3.03–3.20 (m, 2 H), 4.26–4.41 (m, 1 H),
4.72–4.84 (m, 1 H), 5.47–5.54 (m, 1 H), 7.54–7.93 (m, 5 H).
13C NMR (100 MHz, CDCl3): d = 25.57, 27.74, 66.91,
68.88, 75.46, 128.42, 129.46, 129,82, 132.96, 133.98,
134.57, 135.18, 138.78.
(7) (a) Collins, S. P. W.; Djuric, W. Chem. Rev. 1993, 93, 1533.
(b) Mathew, J. Recent Progress in the Chemical Synthesis of
Antibiotics, Lucas G., Vol. II; Springer Verlag: Heidelberg,
1993, 435. (c) Mikolajczyk, M.; Mikina, M.; Jankowska, A.
J. Org. Chem. 2000, 65, 5127. (d) Ghosh, S.; Patra, D. Pure
Appl. Chem. 1996, 68, 597.
Comound 5: cis-isomer, mp 197 °C; 1H NMR (400 MHz,
CDCl3): d = 1.98 (s, 3 H), 2.17–2.38 (m, 2 H), 2.64 [dd,
3J(H,H) = 2.39, 15.96 Hz, 1 H], 2.94 [dd, 3J(H,H) = 9.36,
15.96 Hz, 1 H], 3.17–3.25 (m, 1 H), 3.73 (s, 3 H), 4.64 [dt,
3J(H,H) = 2.38, 8.62 Hz, 1 H]. 13C NMR (100 MHz, CDCl3):
d = 26.91, 29.61, 34.58, 53.11, 54.36, 64.93, 73.21 133.67,
133.75, 138.16, 175.53.
(8) Hanselaer, R.; Samson, M.; Vandewalle, M. Tetrahedron
1978, 34, 2393.
Compound 5: trans-isomer, mp 148 °C; 1H NMR (400 MHz,
CDCl3): d = 2.01 (s, 3 H), 2.15–2.22 (m, 2 H), 2.60 [dd,
3J(H,H) = 4.22, 15.77 Hz, 1 H], 2.92 [dd, 3J(H,H) = 7.7,
15.59 Hz, 1 H], 3.09–3.16 (m, 1 H), 3.73 (s, 3 H), 4.19–4.25
(m, 1 H), 4.64–4.69 (m, 1 H). 13C NMR (100 MHz, CDCl3):
d = 28.01, 29.54, 34.22, 53.03, 54.36, 64.72, 73.94, 133.65,
133.77, 138.16, 138.58, 175.65.
(9) (a) Hudlicky, T.; Price, J. D. Chem. Rev. 1989, 89, 1467.
(b) Thebtaranonth, C.; Thebtaranonth, Y. Tetrahedron 1990,
46, 1385. (c) Survey of cyclopentane ring formation, see:
Larock, R. L. Comprehensive Organic Transformations, 2nd
ed.; Wiley-VCH: New York, 1999, 168–174. (d) Du, Y.;
Lu, X.; Zhang, C. Angew. Chem. Int. Ed. 2003, 42, 1035.
(e) Huart, C.; Ghosez, L. Angew. Chem., Int. Ed. Engl. 1997,
36, 634.
Compound 6: mp 167 °C; 1H NMR (200 MHz, CDCl3):
d = 1.18 [t, 3J(H,H) = 7.16 Hz, 3 H], 2.00–2.14 (m, 1 H),
2.38–2.60 (m, 1 H), 3.60 [dd, 3J(H,H) = 6.00, 11.68 Hz, 1
H], 4.14 [dq, 3J(H,H) = 2.56, 7.14 Hz, 2 H], 4.25–4.57 (m, 2
H), 4.87–4.96 (m, 2 H), 7.20–7.37 (m, 5 H). 13C NMR (50
MHz, CDCl3): d = 13.89, 26.05, 44.83, 53.03, 61.62, 72.27,
128.19, 128.98, 130.38, 133.48, 134.47, 135.41, 137.77,
169.33.
(10) Silva, L. F. Jr. Tetrahedron 2002, 58, 9137.
(11) Typical Procedure. All reactions were performed in oven-
dried glassware under argon. THF was freshly distilled from
potassium-benzophenone. To a solution of 1 (117 mg, 0.3
mmol) in THF (5 mL) at –70 °C LDA (0.22 mL of 1.8 M
solution, 0.4 mmol) was added in one portion. After 1–2 sec
Michael acceptor dissolved in THF was added: 0.45 mmol in
0.5 mL of THF for the synthesis of 4, 7, 8, 9, 10; 0.6 mmol
for 6, and 3 mmol for 5. The mixture was stirred for 5 min,
warmed to r.t., quenched with aq NH4Cl, extracted and
purified by column and preparative TLC chromatography
(hexane/EtOAc as eluent).
Compound 7: mp 232 °C; 1H NMR (400 MHz, CDCl3):
d = 1.90–2.07 (m, 1 H), 2.44–2.55 (m, 1 H), 3.65–3.74 (m, 1
H), 4.41–4.47 (m, 2 H), 4.86 [t, 3J(H,H) = 7.89 Hz, 1 H],
5.46 [d, 3J(H,H) = 5.32 Hz, 1 H], 7.23–7.61 (m, 10 H). 13
C
NMR (100 MHz, CDCl3): d = 26.09, 45.26, 56.95, 71.99,
76.27, 127.55, 128.16, 128.27, 128.69, 132.58, 133.25,
133.78, 134.70, 136.20, 136.79, 196.14.
Compound 1: mp 124 °C; 1H NMR (200 MHz, CDCl3):
d = 2.31–2.46 (m, 2 H), 3.67–3.78 (m, 4 H). 13C NMR (50
MHz, CDCl3): d = 25.93, 43.12, 53.77, 134.51, 135.67,
135.97, 139.83.
Compound 9: trans-isomer, mp 234 °C; 1H NMR (400 MHz,
CDCl3): d = 2.67–2.88 (m, 3 H), 2.92–2.98 (m, 1 H) 4.72 [d,
3J(H,H) = 9.72 Hz, 1 H], 4.76–4.86 (m, 1 H), 7.23–7.28 (m,
3 H), 7.33–7.38 (m, 1 H). 13C NMR (50 MHz, CDCl3):
d = 23.62, 38.26, 42.20, 50.90, 64.25, 112.81, 113.18,
127.28, 128.11, 128.59, 130.03.61, 130.61, 132.91, 133.76,
135.06, 135.12, 139.48.
Compound 2: mp 169 °C; 1H NMR (400 MHz, CDCl3):
d = 1.12–1.16 (m, 2 H), 1.50–1.55 (m, 2 H), 3.20 [tt,
3J(H,H) = 4.77, 7.88 Hz, 1 H]. 13C NMR (100 MHz, CDCl3):
d = 6.06, 32.69, 133.20, 134.87, 137.45, 138.47.
Compound 3: cis-isomer, mp 125 °C; 1H NMR (400 MHz,
CDCl3): d = 1.42 (s, 9 H), 2.13–2.26 (m, 3 H), 2.90–3.08 (m,
2 H), 4.59 [dd, 3J(H,H) = 6.97, 7.43 Hz, 1 H], 4.75–4.80 (m,
1 H). 13C NMR (100 MHz, CDCl3): d = 26.53, 27.81, 28.28,
48.83, 66.23, 75.09, 82.76, 132.48, 133.21, 136.81, 168.86.
Compound 3: trans-isomer, mp 120 °C. 1H NMR (400 MHz,
CDCl3): d = 1.42 (s, 9 H), 2.20–2.31 (m, 1 H), 2.33–2.41 (m,
2 H), 2.76–2.83 (m, 1 H), 3.12–3.21 (m, 1 H), 4.27–4.34 (m,
1 H), 4.62 [t, 3J(H,H) = 6.87 Hz, 1 H], 4.73 [dt,
Compound 10: trans-isomer, mp 216 °C; 1H NMR (500
MHz, CDCl3): d = 1.92 [dddd, 3J(H,H) = 3.40, 6.80, 9.15
Hz, 2J(H,H) = 15.50 Hz, 1 H], 2.60 [dddd, 3J(H,H) = 4.95,
5.80, 8.80 Hz, 2J(H,H) = 15.50 Hz, 1 H], 3.61 [ddd,
3J(H,H) = 6.80, 4.95 Hz, 2J(H,H) = 11.50 Hz, 1 H], 3.82
[ddd, 3J(H,H) = 5.85, 9.10 Hz, 2J(H,H) = 11.50 Hz, 1 H],
4.26 [ddd, 3J(H,H) = 12.00, 8.80, 3.40 Hz, 1 H], 4.42 [d,
3J(H,H) = 12.00 Hz, 1 H], 6.57 [dd, 3J(H,H) = 1.90, 3.40 Hz,
1 H], 6.83 [d, 3J(H,H) = 3.35 Hz, 1 H], 7.65 [d,
3J(H,H) = 2.20, 8.72 Hz, 1 H]. 13C NMR (100 MHz, CDCl3):
d = 26.64, 27.82, 28.59, 49.27, 67.58, 74.68, 82.78, 132.77,
133.28, 136.65, 169.19. Anal. calcd (%) for C16H17Cl5O4S
(482.63): C, 39.82; H, 3.55; Cl, 36.73; S, 6.64. Found: C,
39.93; H, 3.63; Cl, 36.82; S, 6.60.
3J(H,H) = 1.55 Hz, 1 H]. 13C NMR (100 MHz, CDCl3):
d = 28.21, 40.87, 42.65, 45.02, 56.77, 110.04, 111.03,
111.56, 114.71, 123.84, 132.18, 133.96, 136.57, 139.98,
140.18, 143.53, 145.29.
Compound 10: cis-isomer, mp 158 °C; 1H NMR (400 MHz,
CDCl3): d = 2.60–2.89 (m, 4 H), 4.17 [d, 3J(H,H) = 10.08
Hz, 1 H], 4.87–4.95 (m, 1 H), 6.19 [dd, 3J(H,H) = 1.47, 3.30
Hz, 1 H], 6.29 [d, 3J(H,H) = 3.29 Hz, 1 H], 7.24 [d,
3J(H,H) = 1.28 Hz, 1 H]. 13C NMR (100 MHz, CDCl3):
d = 23.03, 37.23, 41.77, 50.53, 62.59, 110.68, 110.86,
112.73, 113.34, 133.55, 133.78, 135.04, 139.56, 144.15,
144.28.
Compound 4: cis-isomer, mp 156 °C; 1H NMR (200 MHz,
CDCl3): d = 2.21–2.33 (m, 2 H), 2.78–2.83 (m, 2 H), 3.31 [t,
3J(H,H) = 10.01 Hz, 1 H], 4.26–4.44 (m, 1 H), 4.72–4.82 (m,
1 H), 5.57–5.65 (m, 1 H), 7.56–7.94 (m, 5 H). 13C NMR (100
MHz, CDCl3): d = 25.02, 28.28, 65.95, 67.85, 75.30, 128.23,
129.35, 129.50,134.17, 134.52, 135.43, 135.84, 139.21.
Compound 4: trans-isomer, oil. 1H NMR (200 MHz,
Synlett 2004, No. 4, 717–719 © Thieme Stuttgart · New York